None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? When the parent or legal representative of the clinical trial subject signs a written consent after hearing the explanation of the purpose, method, and effect of this clinical trial ? Children under 7 years of age diagnosed with cerebral palsy ? Children with developmental delay (if there is a developmental delay in more than one area, such as large movement, small movement, language, and cognition in the standardized developmental test) ? Subjects with no health problems as a result of medical history and physical examination
Exclusion criteria
Exclusion criteria: ? When chromosomal abnormalities or metabolic abnormalities are confirmed ? In case of severe allergic reaction due to intradermal needle or inability to maintain the procedure ? If surgery and hospitalization were performed within the last 3 months ? If there is a change in the dose of anticonvulsant and anticonvulsant drugs within the last 3 months ? If it is difficult to perform rehabilitation treatment with NIRSIT ? If you are currently participating in another clinical trial or plan to participate in another clinical trial during the trial period ? Other cases where the test manager or test manager determines that it is inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Functional near-infrared spectroscopy; fNIRS | — |
Secondary
| Measure | Time frame |
|---|---|
| Check if the device can be worn | — |
Countries
Korea, Republic of
Contacts
Dongguk University Ilsan Hospital